
### [MONDO:0016412](http://purl.obolibrary.org/obo/MONDO_0016412)
**Label:** peripheral hypothyroidism

**Subclasses:** [MONDO:0012360](http://purl.obolibrary.org/obo/MONDO_0012360) (CHNG3), [MONDO:0019995](http://purl.obolibrary.org/obo/MONDO_0019995) (peripheral resistance to thyroid hormones), [MONDO:0012332](http://purl.obolibrary.org/obo/MONDO_0012332) (short stature-delayed bone age due to thyroid hormone metabolism deficiency), [MONDO:0013757](http://purl.obolibrary.org/obo/MONDO_0013757) (hypothyroidism, congenital, Nongoitrous, 6), [MONDO:0010354](http://purl.obolibrary.org/obo/MONDO_0010354) (Allan-Herndon-Dudley syndrome), 

**Corr. equiv. classes:** [Orphanet:171706](http://www.orpha.net/ORDO/Orphanet_171706), [Orphanet:97927](http://www.orpha.net/ORDO/Orphanet_97927), [OMIM:609698](http://purl.obolibrary.org/obo/OMIM_609698), [OMIM:300523](http://purl.obolibrary.org/obo/OMIM_300523), [Orphanet:59](http://www.orpha.net/ORDO/Orphanet_59), [OMIM:614450](http://purl.obolibrary.org/obo/OMIM_614450), [OMIM:609893](http://purl.obolibrary.org/obo/OMIM_609893), 

**Class expressions from DL-Learner:**

- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 45.91%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 45.91%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument))) 45.91%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 45.91%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0031097](http://purl.obolibrary.org/obo/HP_0031097) (Abnormal thyroid-stimulating hormone level) 43.15%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) 43.15%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0004349](http://purl.obolibrary.org/obo/HP_0004349) (Reduced bone mineral density))) 43.15%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0004348](http://purl.obolibrary.org/obo/HP_0004348) (Abnormality of bone mineral density))) 43.15%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0000938](http://purl.obolibrary.org/obo/HP_0000938) (Osteopenia))) 43.15%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0000851](http://purl.obolibrary.org/obo/HP_0000851) (Congenital hypothyroidism))) 43.15%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) and (not ([HP:0000026](http://purl.obolibrary.org/obo/HP_0000026) (Male hypogonadism))) 39.29%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 38.82%
- [HP:0031097](http://purl.obolibrary.org/obo/HP_0031097) (Abnormal thyroid-stimulating hormone level) 37.86%
- [HP:0002925](http://purl.obolibrary.org/obo/HP_0002925) (Increased thyroid-stimulating hormone level) 37.86%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 37.34%


